chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: VARCEL
Clinical narrative: Information has been received from a Registered Nurse with no known drug reactions or allergies, who on 14-MAY-2008 was vaccinated with first dose of VARIVAX (Oka/Merck) (lot # 660037/1848U), 0.5ml subcutaneously, then on 16-JUN-2008 she received second dose of VARIVAX (Oka/Merck) (lot # 660037/1848U).  Concomitant therapy included ZOLOFT, XANAX, estrogens, PREMARIN and LASIX.  On 10-NOV-2008 VARICELLA antibody titers were tested and the result was negative.  At the moment of the report the patient status was not recovered - negative titers.  No further information is available.
Age: 1.0
Sex: F
Vaccine: DTAP, FLUX, MMR, VARCEL
Symptoms: Rash
Clinical narrative: Information has been received from a physician concerning her 12 month old daughter who on an unspecified date was vaccinated subcutaneously with a 0.5 ml dose of VARIVAX (Oka/Merck).  Secondary suspect therapy included MMR II (Wistar RA 27/3).  Other concomitant therapy included "flu" and DTAP.  It was reported that "within one week of receiving VARIVAX (Oka/Merck)", the patient developed a mild rash but was not fussy.  The patient sought physician's medical attention.  Subsequently, on an unspecified date, the patient recovered.  The physician's older daughter developed an adverse experience after receiving a dose of VARIVAX (Oka/Merck) (WAES 0811USA02274).  Additional information has been requested.
Age: 1.1
Sex: F
Vaccine: FLU3, MMR, VARCEL
Symptoms: Injection site erythema, Injection site induration, Injection site mass, Injection site warmth, Urticaria
Clinical narrative: Information has been received from a registered nurse (RN) concerning a 13 month old female with eczema who on 31-Oct-2008 was vaccinated subcutaneously in the left triceps with a 0.5ml dose of VARIVAX (Oka/Merck) (Lot#661649/1156X). Concomitant therapy included acetaminophen (Tylenol). On 10-Nov-2008 the patient developed a red nodule at injection site that was warm to touch. On 13-Nov-2008 the patient had an office visit and was examined by physician. On that day the patient had a non-tender by 1 cm erythematous patch with a 1cm induration at the injection site. The patient was treated with Hydrocortisone cream. At the time of the report, 13-Nov-2008, the patient had not recovered from the events. Follow-up information was received from the R.N. on 08-Jan-2009 concerning a 13 month old white female with eczema. On 31-Oct-2008, at 9:00 a.m. the patient was vaccinated subcutaneously in the left tricep with a first dose of VARIVAX (Oka/Merck)  (Lot#561649/1156X). On the same day, at 9:00am, the patient also received a first dose of MMR II (Lot # 662437/1251X) subcutaneously in the right tricep and a first dose of FLUZONE (lot#UT2782CA) intramuscularly in the left deltoid. There was no illness at the time of vaccination. On 10-Nov-2008, the patient developed bump at the left tricep area. On 13-Nov-2008 the patient came into the office for observation. She had a 2cm by 1cm area pink patch with induration (1cm). The area had no apparent tenderness and was not warm. It was reported that the area "was warm prior and also was more red" and the "site was improving". The patient was not afebrile. Topical hydrocortisone acetate cream was placed to the area. The patient recovered on an unspecified date. Information / Follow-up information received on 08-Jan-2009 contained the following adverse experiences: hives with eggs (November 2008). Additional information is not expected.
Age: 2.7
Sex: F
Vaccine: VARCEL
Symptoms: Rash pustular, Varicella post vaccine
Clinical narrative: Information has been received from a physician concerning her 2 year and 9 month old daughter who was "previously" vaccinated with a dose of VARIVAX (Oka/Merck).  It was reported that the patient developed pustules and a mild case of chicken pox after her sister received her injection of VARIVAX (Oka/Merck).  The outcome of the patient was not reported.  The patient's sister developed a mild rash after receiving VARIVAX (Oka/Merck) (WAES 0811USA02164).  Additional information has been requested.
Age: 20.0
Sex: F
Vaccine: VARCEL
Symptoms: Rash vesicular, Varicella zoster virus serology positive
Clinical narrative: Information has been received from a registered nurse concerning a 20 year old female patient with no know drug allergies, no seasonal/environmental allergies and without birth defects and pre-existing medical conditions, who on 28-AUG-2008 was vaccinated with the first dose of VARIVAX (Oka/Merck) (Lot number 659722/1877U) IM in the right deltoid. On 21-OCT-2008, the patient went for the second dose of VARIVAX (Oka/Merck), she reported a "very small blister like rash" distal to right deltoid administration site of the first dose of VARIVAX (Oka/Merck) given on 28-AUG-2008. The patient reported this reaction to the primary care physician when she noticed the rash on 29-AUG-2008 early in the morning (previously reported on the same day), and no treatment was received. The lesions lasted three days. On 03-SEP-2008, the patient recovered. The registered nurse consulted with the certified registered nurse practitioner (immediate supervisor) and the second dose of VARIVAX (Oka/Merck) was not given. Titers drawn indicated positive immunity (1.3). No further information is available.
Age: 1.2
Sex: F
Vaccine: VARCEL
Symptoms: Underdose, Varicella post vaccine
Clinical narrative: Information has been received from a pharmacist concerning his granddaughter (14 month old female) who at about age 12 months (approximately August 2008) was vaccinated with a half dose of VARIVAX (Oka/Merck). Pharmacist does not know why she received a half dose. His granddaughter then developed "atypical chickenpox" about 2 weeks age (on about 08-Oct-2008). The patient recovering. The patient sought medical attention and was seen by a doctor. No further information is available.
Age: 5.0
Sex: F
Vaccine: VARCEL
Symptoms: Pruritus, Varicella post vaccine
Clinical narrative: Information has been received from a nurse concerning a 5 year old female who received her first dose of VARIVAX (Oka/Merck) (lot# 647719/1248N) on 19-MAR-2004 and her second dose of VARIVAX (Oka/Merck) on 13-JUN-2007 (0.5 ml, subcutaneously). Two days ago (approximately 20-OCT-2008) the patient developed chicken pox. The patient was seen in the office today (22-OCT-2008) and she has less than 50 lesions in her back. The patient is recovering. Follow up information has been received from a registered nurse concerning a 5-year-old female student with no pre-existing allergies, birth defects or medical conditions. She was vaccinated in the left lateral thigh on 19-MAR-2007 and 13-JUN-2007 with a first and second dose of VARIVAX (Oka/Merck) (lot# 658435/1248N and 657185/0301U, respectively). Subsequently, on 22-OCT-2008, the patient developed <50 lesions on her back. It was reported that they were itching and that she did not have a fever. No diagnostic or laboratory tests were performed. The patient recovered as of 27-OCT-2008. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Wrong drug administered
Clinical narrative: Information has been received from a nurse concerning a patient who was vaccinated with VARIVAX (Oka/Merck) instead of ZOSTAVAX (Oka/Merck) (MSD). No adverse effect reported. The nurse stated this was not a product confusion as they do not have ZOSTAVAX (Oka/Merck) in their office. It was unspecified the patient sought medical attention. Additional information has been requested.
Age: 68.0
Sex: M
Vaccine: VARCEL
Symptoms: Wrong drug administered
Clinical narrative: Information has been received from a medical assistant concerning a 68 year old male who on 15-OCT-2008 was vaccinated with VARIVAX (Oka/Merck) 0.5ml IM.  But the patient should have received ZOSTAVAX.  No adverse effects noted.  Medical assistant reported all VARIVAX (Oka/Merck) she administered were given IM.  Telephone follow up information has been received from the medical assistant.  She indicated that the person who orders the vaccines put the vaccines put the vaccine in the wrong place, leading to medication error.  The office has taken measures to prevent this type of error in the future.  Additional information is not expected.
Age: 1.0
Sex: M
Vaccine: DTAPIPV, HIBV, MMR, PNC, VARCEL
Symptoms: Blister, Rash, Varicella post vaccine
Clinical narrative: Information has been received from a licensed nurse concerning a 12 month old male patient with no known pertinent medical history, and no known drug reaction, who on 13-OCT-2008 was vaccinated with a dose of VARIVAX (Lot No 661980/1145X), 0.5 ml, subcutaneously. That same day, the patient also received MMR, PREVENAR, KINRIX, and ACTHIB. There was no other concomitant therapy. The licensed nurse reported that on 23-OCT-2008, the patient was seen in the office with a rash with blisters on face, behind ear, trunk and elsewhere (reported as chicken pox that developed last week). The licensed nurse reported that the patient was not exposed to chicken pox prior to vaccination. No treatment was required. At the time of the report the patient was recovering. This is one of two patients from the same source. Further information has been requested.
Age: 1.0
Sex: M
Vaccine: DTAPIPV, HIBV, MMR, PNC, VARCEL
Symptoms: Rash, Varicella post vaccine
Clinical narrative: Information has been received from a licensed nurse concerning a 12 month old male patient with no known pertinent medical history, and no known drug reactions, who on 08-OCT-2008 was vaccinated with a dose of VARIVAX (Oka/Merck) (Lot # 661980/1145X), 0.5 ml, subcutaneously.  That same day, the patient was also vaccinated with MMR II, PREVNAR, DTAP - IPV, and ACTHIB.  there was no other concomitant therapy.  The licensed nurse reported that on 17-OCT-2008, the patient's mother called the office to report the child had a rash.  On 22-OCT-2008, the patient was seen in the office for chicken pox.  The spots were healing when seen.  The licensed nurse reported that no treatment was required.  This is one of two reports from the same source.  Further information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Wrong drug administered
Clinical narrative: Information has been received from a physician concerning an adult patient who was vaccinated with VARIVAX (Oka/Merck) instead of ZOSTAVAX (Oka/Merck) by mistake. It was stated that it was not due to product confusion. No adverse effect was reported. It is unknown if the patient sought medical attention. No further information is available.
Age: 4.0
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Feeling abnormal
Clinical narrative: Information has been received from a licensed visiting nurse concerning a 4 year old female who on 23-OCT-2008 was vaccinated with (lot # not reported), and second dose of MMR II (manufacturer unspecified). Concomitant therapy included FLUMIST given on 11-OCT-2008. The patient's parents contacted the physician last night, 23-OCT-2008, because the patient stated she "didn't feel good". No fever, nausea or vomiting noted. The patient is recovering. Additional information has been requested.
Age: 10.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Initial follow-up information has been received from a physician concerning a 10 year old male student with no pre-existing allergies, birth defects or medical conditions who was vaccinated with a first dose of VARIVAX (Oka/Merck) (lot # reported as 05404) SC in left arm on 05-SEP-2003. His second dose was received on 05-AUG-2008. There was no illness at the time of vaccination. On 23-AUG-2008 the patient developed mild chickenpox on his torso. The patient was seen at physician's office on 09-SEP-2008 and there were hardly any spots visible. There were no relevant diagnostic tests performed. He recovered on 09-SEP-2008. No further information is available.
Sex: M
Vaccine: VARCEL
Symptoms: Wheezing
Clinical narrative: Information has been received from a physician concerning a boy who was vaccinated with VARIVAX (Oka/Merck) 0.5ml (therapy started date, route, site unknown) and experienced wheezing at some unspecified time after receiving the vaccine (past few weeks). The patient sought medical attention and treatment was unknown. At the time of report patient had recovered. Additional information has been requested.
Age: 13.0
Sex: F
Vaccine: VARCEL
Symptoms: Similar reaction on previous exposure to drug, Varicella post vaccine
Clinical narrative: Information has been received from a physician concerning his daughter, a 13 year old female who on 18-SEP-2008 was vaccinated with the second dose of VARIVAX (lot # 660331/0485X). The patient was also vaccinated with FLUVIRIN on 13-OCT-2008. Subsequently the patient experienced a chicken pox outbreak and had 20 lesions. The patient also had " a local chicken pox like rash" after the first dose of VARIVAX on 18-APR-2007. At the time of the report, the patient was not recovered. The patient sought medical attention by contacting the physician's office. Additional information has been requested.
Sex: F
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Information has been received from a physician and a licensed practical nurse concerning a female who was recently vaccinated with the second dose of VARIVAX (Oka/Merck). The physician reported that the patient experienced injection site reaction after receiving the vaccine; on follow-up the nurse reported that the patient experienced redness and swelling at the injection site. At the time of the report the patient had recovered. The patient sought unspecified medical attention. This is one of several reports received from the same source. Additional information hs been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a nurse concerning a patient who was vaccinated with VARIVAX (Oka/Merck) (therapy started date, route, site unknown) developed breakthrough chicken pox after the second dose. Patient's medical history and drug reactions/allergies were unspecified by reporter. The reporting nurse noted the patient's case of chicken pox was mild with less than 50 lesions and sought medical attention. On an unspecified date, patient had recovered. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: VARCEL, VARZOS
Symptoms: Wrong drug administered
Clinical narrative: Information has been received from a pharmacist concerning a patient who on an unspecified date was vaccinated with VARIVAX (Oka/Merck) when ZOSTAVAX (Oka/Merck) was intended. This was a misuse error not product confusion. No symptoms were noted. Additional information has been requested.
Sex: M
Vaccine: VARCEL
Symptoms: Wrong drug administered
Clinical narrative: Information has been received from a physician assistant concerning a male patient who on 17-NOV-2008 was vaccinated with VARIVAX (Oka/Merck) instead of ZOSTAVAX (Oka/Merck). No symptoms was reported. Further information has been requested.
Age: 63.0
Sex: M
Vaccine: VARCEL
Symptoms: Wrong drug administered
Clinical narrative: Information has been received from a healthcare worker concerning a 63 year old male patient, who was scheduled to receive ZOSTAVAX (Oka/Merck), received a dose of VARIVAX (Oka/Merck) and had not experienced any known symptoms. Follow-up information was received from a physician reported that the patient received a dose of VARIVAX (Oka/Merck) in September 2008, 9 weeks ago at another clinic and was told to come back in 2 months for another dose of ZOSTAVAX (Oka/Merck). When the patient called the clinic he received the vaccine at, the clinic said they were out of ZOSTAVAX (Oka/Merck), but to call another clinic. The patient called the clinic where the reporting physician was working at. The physician told the patient that ZOSTAVAX (Oka/Merck) was a one time shot. The physician looked into the situation and determined that the patient received VARIVAX (Oka/Merck). The physician recommended that the patient should receive ZOSTAVAX (Oka/Merck), but the clinic had it on backorder until December. The physician was not sure what the patient would do. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a nurse concerning a patient who was vaccinated with VARIVAX (Oka/Merck) (therapy started date, route, site unknown) developed breakthrough chicken pox over a year after the second dose.  Patient's medical history and drug reactions/allergies were unspecified by reporter.  The patient's case of chicken pox was mild less than 50 lesions and sought medical attention.  At the time of report patient had recovered.   This is one of several reports received from the same source.  Additional information has been requested.
Sex: F
Vaccine: VARCEL
Symptoms: Rash
Clinical narrative: Information has been received from a physician concerning a female patient who on 03-NOV-2008 was vaccinated with a 0.5 ml dose of VARIVAX (Oka/Merck).  The physician reported that on 14-NOV-2008 the patient developed a rash on her truck after vaccination.  The patient sought unspecified medical attention.  Additional information has been requested.
Age: 4.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a nurse via a sales representative concerning an approximately 4 year old male who in 2005 was vaccinated with a first dose of VARIVAX vaccine (Oka/Merck). On approximately 06-OCT-2008, "this week", the patient experienced chickenpox. At the time of reporting, the patient's chickenpox persisted. No additional AE information reported. Follow up information was received from a registered nurse who stated that the mother of a child from a child care center called about this adverse experience. She has no information on child, doctor, or the event. Attempts were being made to verify the existence of an identifiable patient and reporter have been unsuccesful. No further information was available.
Age: 35.0
Sex: F
Vaccine: VARCEL
Symptoms: Conjunctivitis infective, Ocular hyperaemia, Ophthalmological examination
Clinical narrative: Information has been received from a 35 year old female pharmacist concerning herself with no pertinent medical history who on 15-AUG-2008 was vaccinated with the first dose of VARIVAX (Merck) subcutaneous and on 16-SEP-2008 was vaccinated with the second dose of VARIVAX (Merck) subcutaneous. There was no concomitant medication. "About 10-14 days after getting the first dose of" VARIVAX (Merck), which was on approximately 25-AUG-2008- 29-AUG-2008, the patient developed pink eye and performed eye exams (results were unspecified). The pharmacist was treated with gentamycin and the infection resolved about 10 days later. At the time of the report, there was no pain or discharge of the eye, but the patient's eye was still red and she was using PRED FORTE. The patient sought medical attention 3 times. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Wrong drug administered
Clinical narrative: Information has been received from a patient who "a week ago" was vaccinated with VARIVAX (Oka/Merck).  The patient reported that she went to a clinic to have ZOSTAVAX (Oka/Merck) (MSD), but the vaccine that was given to her was VARIVAX (Oka/Merck) instead of ZOSTAVAX (Oka/Merck) (MSD).  Additional information has been requested.
Age: 7.0
Sex: F
Vaccine: VARCEL
Symptoms: Erythema, Nodule
Clinical narrative: Information has been received from a medical assistant concerning a three elementary school aged patient about the age of 8 or 9 who received the second dose of VARIVAX (Merck) (lot # "0996 Y or X") on the same day the patient developed a raised knot, reddened area and about three inches in diameter.  The onset of the symptoms was not specified.  The symptoms resolved in an unspecified period of time.  No other symptoms or treatment reported.  Follow-up information was received from a medical assistant who identified one of the patients as a 7 year old female patient who received the second dose of VARIVAX (Merck).  The medical assistant reported that she could not remember any other information regarding the patient.  This is one of several reports received from the same source.  Additional information has been requested.
Age: 5.0
Sex: F
Vaccine: VARCEL
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a consumer concerning his daughter, a 5 year old female who in October 2007 was vaccinated with VARIVAX (Merck). Subsequently, on 07-Oct-2008 it was reported the daughter was diagnosed with zoster. She is being treated with "Zorivax". Whether she sought medical attention and the patient outcome were unknown. Additional information has been requested.
Sex: M
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a physician concerning her son who was vaccinated with VARIVAX vaccine (Oka/Merck) (lot # not provided). Subsequently the patient experienced a mild case of breakthrough chickenpox on the back of his neck and back. Subsequently, the patient recovered from mild breakthrough chickenpox. The patient sought medical attention. Additional information has been requested
Age: 1.1
Sex: F
Vaccine: MMR, PNC, VARCEL
Symptoms: Body temperature, Varicella post vaccine
Clinical narrative: Information has been received from a certified medical assistant concerning a 26 month female with drug hypersensitivity to CEFTIN and no illness at the time of vaccination who on 22-SEP-2007 was vaccinated subcutaneously in the left arm with VARIVAX (Merck) (lot # 658409/1178U). Concomitant therapy included MMR II (MSD) (lot # 657244/0527U) subcutaneously in the right arm and PREVNAR (lot # 85407K) intramuscularly in the right arm which were vaccinated on the same day. On 25-OCT-2008 the patient developed varicella. The patient visited the office. She had 10-15 chicken pox all over with a maximum temperature of 99F. The patient was treated with CALAMINE LOTION and TYLENOL. On unknown date the patient recovered. No further information is available.
Age: 10.0
Sex: F
Vaccine: VARCEL
Symptoms: Rash vesicular, Varicella post vaccine
Clinical narrative: Information has been received from a physician concerning a 10 year old female with asthma who on 22-OCT-1999 received her first dose of VARIVAX (Merck) (Lot # not provided) and on 17-SEP-2008 received the second dose of VARIVAX (Merck), 0.5ml, subcutaneously (lot # 661651/0989X). There was no concomitant medication or drug allergy. On 07-OCT-2008 the patient experienced atypical varicella. The vesicular rash consisted of "about 20 lesions" with a distribution on the face and bilateral arms. No lab diagnostics studies was performed. The patient's atypical varicella persisted. The patient sought medical attention. Additional information has been requested. This is one of several reports received from the same source.
Age: 1.6
Sex: F
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a physician concerning a 24 month old female who on 23-MAY-2008 was vaccinated with her first dose of 0.5 mL VARIVAX (Oka/Merck) (Lot 660217/0167X) injection (site not reported).  On 06-NOV-2008 the patient experienced minor case of chicken pox.  The patient recovered "within the last week or two."  Unspecified medical attention was sought.  There was no product quality complaint.  No further information is expected.
Age: 11.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site induration, Injection site swelling, Injection site vesicles
Clinical narrative: Information has been received from a physician concerning a 11 year old female who on 24-JUN-1998 received her first dose of VARIVAX (Merck) (lot # not provided) and on 02-OCT-2008 received her second dose of VARIVAX (Merck), 0.5ml, subcutaneously (lot # 661651/0989X). There was no concomitant medication. The patient had no medical history or drug allergy. On 03-OCT-2008 the patient experienced redness, swelling, induration and vesicular lesions at the injection site of the right upper arm. The patient sought medical attention and was prescribed a course of AUGMENTIN. On 06-Oct-2008, follow-up exam revealed the symptoms resolving. Additional information has been requested. This is one of several reports received from the same source.
Sex: U
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a registered nurse concerning an elementary school aged child patient with medical history and allergy unspecified who on unspecified date was vaccinated with VARIVAX (Oka/Merck) (Lot # was not provided).  After receiving 2 doses of VARIVAX (Oka/Merck) (Lot # was not provided), the patient experienced chicken pox.  The patient sought medical attention, but lab and diagnostic tests was unspecified.  No further information was provided.  Additional information has been requested.
Age: 3.0
Sex: M
Vaccine: HEPA, VARCEL
Symptoms: Blister, Herpes zoster
Clinical narrative: Information has been received from a patient's mother concerning her 3 year old son, with no pertinent medical history and no drug allergies / drug reactions. The patient's mother reported that her son was vaccinated with a dose of VARIVAX (Oka/Merck) (lot# 656172/1498F) "one year ago". There were no concomitant medication. On 24-Nov-2008 the patient was diagnosed with shingles. The patient sought medical attention with the pediatrician. No laboratory diagnostic studies were performed. The patient had not recovered at the time of the report. Follow up information was received on 23-Dec-2008: the patient received the first dose VARIVAX (Oka/Merck) (lot# 656172/14987) on 16-May-2007 and in the same day received the first dose of HEP A (lot# 666993/000IU). It was reported that clustered vesicles on his left elbow clinically consisented with Zoster. The patient sought medical attention. Additional information has been requested.
Age: 71.0
Sex: F
Vaccine: VARCEL
Symptoms: Wrong drug administered
Clinical narrative: Information has been received from a physician concerning a 71 year old female with no pertinent medical history and no drug reactions/allergies who in May 2008, was vaccinated with VARIVAX vaccine (Oka/Merck) instead of vaccination of ZOSTAVAX vaccine (Oka/Merck) because the person administering the vaccine confused the VARIVAX vaccine (Oka/Merck) with ZOSTAVAX vaccine (Oka/Merck). Concomitant therapy included LEXAPRE. The patient had no adverse event reported. No lab or diagnostic studies were performed. It was reported that the patient sought unspecified medical attention. Further information has been requested
Age: 8.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site pain, Injection site swelling, Injection site urticaria
Clinical narrative: Information has been received from a health professional concerning an 8 year old female who on 21-OCT-2008 received the second dose of VARIVAX (Merck), subcutaneously in the right lower arm (lot# 661536/0954X). On 21-OCT-2008 the patient experienced painful at injection site, a 3 inch x 5 inch welt at injection site and swelling. At the time of the report, the outcome of the patient was unknown. The patient sought unspecified medical attention. Additional information has been requested.
Age: 1.6
Sex: M
Vaccine: VARCEL
Symptoms: Skin lesion, Varicella post vaccine
Clinical narrative: Information has been received from a physician concerning a 28 month old male (child) who was vaccinated with VARIVAX (Merck). Subsequently the patient developed a couple varicella lesions. The physician was not sure whether the patient was vaccinated or developed wild varicella. The physician was not interested in VZVID. Subsequently, the patient recovered from varicella lesions months ago. It was reported that the patient sought medical attention: seen in office. This was one of two reports from the same resource. The other patient was a newborn sibling (WAES # 0810USA02126). On 09-OCT-2008, the physician's nurse telephoned to indicated that per the office's records the patient had not been vaccinated with VARIVAX (Merck) and was behind on some of his immunizations. On 10-OCT-2008, the physician's MVX stated that the patient was vaccinated with VARIVAX (Merck) at the health department. The patient had just a handful of lesions that were crusting over when the baby was born and he was the presumed contact. Additional information was received from the patient's HCP physician who reported that a 19 month old otherwise health child received VARIVAX (Merck) and subsequently developed a "bunch" of lesions. A newborn sibling developed varicella and was hospitalized, treated with acyclovir. There was no evidence of meningitis. The baby had recovered; he was now approximately 5 months old an otherwise health (no history of immunocompromise) (WAES# 0810USA02126). Additional information has been requested.
Age: 38.0
Sex: F
Vaccine: VARCEL
Symptoms: Diarrhoea, Varicella, Varicella post vaccine
Clinical narrative: Information has been received from a Registered Nurse concerning a 38 year old female patient with penicillin allergy and medical history unknown, who on 14-NOV-2008 was vaccinated with first dose of VARIVAX (Lot # 658967/1521U), 0.5ml, subcutaneously. Concomitant therapy included FEMCON FE (was reported "FEMCON"). On 24-NOV-2008 the patient experienced chicken pox rash and diarrhea after she received her first dose of VARIVAX. There were no laboratory diagnostic studies performed. At the time of the report on 25-NOV-2008, the patient was "recovering". The patient sought medical attention by calling the practice. Additional information has been requested.
Age: 37.0
Sex: M
Vaccine: VARCEL
Symptoms: Pyrexia, Rash vesicular, Varicella post vaccine
Clinical narrative: Information has been received from a physician concerning a 37 year old male who on 10-SEP-2008 received the first dose of VARIVAX vaccine (Oka/Merck), 0.5ml, subcutaneously into the left arm (lot # 660672/0432X). There was no concomitant medication. The patient had no medical history of drug allergy. The patient presented to the office today on 28-OCT-2008 with a "chickenpox" rash on his head, chest, and arms. The patient had a fever yesterday before the rash appeared. The patient's chickenpox rash and fever persisted. Follow up information has been received form a physician who indicated that on 09-OCT-2008, the patient was vaccinated with the first dose of VARIVAX vaccine. On 26-NOV-2008 the patient developed a fever for 1-2 days, generalized rash with no coughing and no shortness of breath. The patient also developed a skin vesicular papular multiple 60-100. The patient's temperature was 96 and lungs were clear. Subsequently, the patient recovered from the adverse events. Additional information is not expected.
Age: 12.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Information has been received from a license practical nurse concerning a 12 year old female who on 08-SEP-2008 received the second dose of VARIVAX (Merck) (Lot#661562/0996X) SQ in left arm and  the first dose of MENACTRA (Lot#U2726AA) IM in right arm. On 09-SEP-2008 the patient experienced redness and swelling at injection site of VARIVAX (Merck). At the time of report on 13-OCT-2008, the patient had recovered. Additional information has been requested.
Age: 10.0
Sex: F
Vaccine: VARCEL
Symptoms: Skin lesion
Clinical narrative: Information has been received from a physician concerning a 10 year old female who was vaccinated with a dose of VARIVAX (lot # not reported) when she was 12 months old, approximately in 1999. Last week, on approximately 21-OCT-2008 the patient developed a case of breakthrough (15 lesions). The patient sought medical attention at physician's office. At the time of reporting, she is recovering. Additional information has been requested.
Sex: U
Vaccine: VARCEL, VARZOS
Symptoms: Wrong drug administered
Clinical narrative: Information has been received from a registered nurse (R.N.) concerning a patient who on 28-OCT-2008 was vaccinated with a dose of VARIVAX (Merck) instead of ZOSTAVAX (Merck) (MSD). No symptoms reported. Additional information has been requested.
Age: 1.8
Sex: M
Vaccine: VARCEL
Symptoms: Blister
Clinical narrative: Information has been received from a registered nurse concerning a 22 month old male with no known allergies who on an unspecified date was vaccinated with VARIVAX (Oka/Merck) (lot number, injection site and route not reported).  On 25-NOV-2008 the patient was brought to the physician's office with a 3 day history of approximately 30 erythematous papules with underlying vesicles.  Subsequently, the patient recovered from the events.  It was also reported that the patient's events were ongoing.  Additional information is not expected.
Age: 1.0
Sex: M
Vaccine: HEP, HEPA, MMR, VARCEL
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a physician concerning a 15 month old male who on 02-JUL-2008 was vaccinated subcutaneously with a first 0.5 ml dose of VARIVAX (lot # 659935/1900U). Concomitant therapy included MMR II, RECOMBIVAX HB (manufacturer unknown) and VAQTA (manufacturer unknown). Subsequently on 22-OCT-2008 the patient experienced shingles on his left leg after the vaccination. The patient sought medical attention, and lab test "DSA test for varicella-zoster virus" was performed. At the time of reporting, 29-OCT-2008, the patient had not recovered. Additional information has been requested.
Age: 12.0
Sex: M
Vaccine: VARCEL
Symptoms: Upper respiratory tract infection, Varicella, Varicella post vaccine
Clinical narrative: Initial and follow-up information has been received from a physician concerning a 13 year old male patient who on 29-JUN-1998 was vaccinated subcutaneously with the first dose of VARIVAX (Merck) (Lot # 624644/1329E) and the second dose of VARIVAX (Merck) (Lot # 657109/0444U) on 22-MAY-2007. In March 2008, the patient experienced varicella rash >50 spots. <100 spots noted, with mild prodromal upper respiratory tract infection (URI) like illness. No fever. 2 days with URI illness and 5-6 days of rash. Rash observed by 3 friends: family practice, dermatology and pediatrics. The patient recovered 1 week later. This is one of two reports received from the same source. Additional information is not expected.
Age: 8.0
Sex: U
Vaccine: VARCEL
Symptoms: Erythema, Induration
Clinical narrative: Information has been received from a medical assistant concerning an elementary school aged patient about the age of 8 or 9 who received the second dose of VARIVAX (Oka/Merck) (lot # "0996 Y or X" ) on the same day the patient developed a raised knot, reddened area and about three inches in diameter.  The onset of the symptoms was not specified.  The symptoms resolved in an unspecified period of time.  No other symptoms or treatment reported.  In follow up the medical assistant reported that she could not remember any other information regarding the patient.  This is one of several reports received from the same source.  Additional information has been requested.
Age: 49.0
Sex: F
Vaccine: VARCEL
Symptoms: Antinuclear antibody negative, Blood pressure increased, C-reactive protein normal, Ear pain, Full blood count normal
Clinical narrative: Information has been received from nurse practitioner concerning a 49 year old female patient with hypertension who on 11-SEP-2008 was vaccinated with a dose of VARIVAX (Oka/Merck) (lot # 658412/1024U).  On 12-SEP-2008 the patient experienced general lymphadenopathy.  The nurse practitioner reported that the patient received the same vaccine several years ago in another state but a recent titer was negative.  The patient was given a course of an unspecified antibiotic and recovered.  The patient sought unspecified medical attention.  Follow up information was received from the nurse practitioner reported that the patient was a Caucasian registered nurse who on 11-SEP-2008 at 12:30 PM was vaccinated in her left upper arm with a second dose of VARIVAX (Oka/Merck) (lot # 658412/1024U).  After receiving the vaccine, at 12:45 PM, the patient began feeling "hot" in mid sternum, neck and ears, heart rate increased to 115-120, palpitations, blood pressure increased and tachypnea.  The following day, the patient's lymph nodes in neck were swollen on left side, her left ear was painful.  The injection site was hot, tender with 4 cm area of induration.  On 07-NOV-2008 complete blood cell count, blood chemistry test, serum C-reactive protein test and serum antinuclear antibodies test were performed and the results were within normal limit.  VARICELLA titer results were received on 26-JAN-2009 as 0.97 = equivocal.  It was reported that a previous titer was positive on 07-NOV-2008 (1.42).  At the time of the report. all the events recovered except the blood pressure remained elevated.  Additional information has been requested.
Age: 49.0
Sex: F
Vaccine: VARCEL
Symptoms: Heart rate increased, Injection site induration, Injection site pain, Injection site warmth, Laboratory test normal
Clinical narrative: Information has been received from nurse practitioner concerning a 49 year old female patient with hypertension who on 11-SEP-2008 was vaccinated with a dose of VARIVAX (Oka/Merck) (lot # 658412/1024U).  On 12-SEP-2008 the patient experienced general lymphadenopathy.  The nurse practitioner reported that the patient received the same vaccine several years ago in another state but a recent titer was negative.  The patient was given a course of an unspecified antibiotic and recovered.  The patient sought unspecified medical attention.  Follow up information was received from the nurse practitioner reported that the patient was a Caucasian registered nurse who on 11-SEP-2008 at 12:30 PM was vaccinated in her left upper arm with a second dose of VARIVAX (Oka/Merck) (lot # 658412/1024U).  After receiving the vaccine, at 12:45 PM, the patient began feeling "hot" in mid sternum, neck and ears, heart rate increased to 115-120, palpitations, blood pressure increased and tachypnea.  The following day, the patient's lymph nodes in neck were swollen on left side, her left ear was painful.  The injection site was hot, tender with 4 cm area of induration.  On 07-NOV-2008 complete blood cell count, blood chemistry test, serum C-reactive protein test and serum antinuclear antibodies test were performed and the results were within normal limit.  VARICELLA titer results were received on 26-JAN-2009 as 0.97 = equivocal.  It was reported that a previous titer was positive on 07-NOV-2008 (1.42).  At the time of the report. all the events recovered except the blood pressure remained elevated.  Additional information has been requested.
Age: 49.0
Sex: F
Vaccine: VARCEL
Symptoms: Lymphadenopathy, Palpitations, Tachypnoea, Varicella zoster virus serology positive
Clinical narrative: Information has been received from nurse practitioner concerning a 49 year old female patient with hypertension who on 11-SEP-2008 was vaccinated with a dose of VARIVAX (Oka/Merck) (lot # 658412/1024U).  On 12-SEP-2008 the patient experienced general lymphadenopathy.  The nurse practitioner reported that the patient received the same vaccine several years ago in another state but a recent titer was negative.  The patient was given a course of an unspecified antibiotic and recovered.  The patient sought unspecified medical attention.  Follow up information was received from the nurse practitioner reported that the patient was a Caucasian registered nurse who on 11-SEP-2008 at 12:30 PM was vaccinated in her left upper arm with a second dose of VARIVAX (Oka/Merck) (lot # 658412/1024U).  After receiving the vaccine, at 12:45 PM, the patient began feeling "hot" in mid sternum, neck and ears, heart rate increased to 115-120, palpitations, blood pressure increased and tachypnea.  The following day, the patient's lymph nodes in neck were swollen on left side, her left ear was painful.  The injection site was hot, tender with 4 cm area of induration.  On 07-NOV-2008 complete blood cell count, blood chemistry test, serum C-reactive protein test and serum antinuclear antibodies test were performed and the results were within normal limit.  VARICELLA titer results were received on 26-JAN-2009 as 0.97 = equivocal.  It was reported that a previous titer was positive on 07-NOV-2008 (1.42).  At the time of the report. all the events recovered except the blood pressure remained elevated.  Additional information has been requested.
Age: 4.0
Sex: M
Vaccine: VARCEL
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a physician concerning a 4 year old male patient (his nephew) who in approximately August 2008, was vaccinated with his second dose of VARIVAX (Oka/Merck) (Lot # unspecified).  Around 01-NOV-2008, the patient developed shingles.  The patient sought medical attention.  At the time of reporting (02-DEC-2008) the outcome of the patient was unknown.  This is one of several reports from the same source.  Additional information has been requested.
Age: 6.0
Sex: F
Vaccine: VARCEL
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a physician concerning a female patient who at the age of 12 months (date unspecified) was vaccinated with a dose of VARIVAX (Oka/Merck).  At the age of 6 years old she developed shingles on her leg that resolved and was uncomplicated.  The patient sought medical attention at the office.  No further information is available.
Age: 8.0
Sex: F
Vaccine: VARCEL
Symptoms: Antibody test negative, Varicella zoster serology negative
Clinical narrative: Information has been received from a Registered Nurse concerning an 18 year old female patient with no pertinent medical history or drug reactions or allergies who on 01-SEP-1998 was vaccinated with VARIVAX (Oka/Merck) (Lot # 626959/0846H).  Concomitant therapy included ENGERIX-B.  Subsequently, laboratory data revealed the patient had a low VARICELLA titer.  The patient sought medical attention office visit.  Additional information has been requested.
Age: 1.5
Sex: M
Vaccine: VARCEL
Symptoms: Rash papular, Rash vesicular, Varicella post vaccine
Clinical narrative: Information has been received from a Registered Nurse concerning a 13 year old white male with unknown medical history and no known drug allergies who on 22-JAN-1997 was vaccinated with a first dose of VARIVAX (Oka/Merck) (Lot # not available).  On 17-NOV-2008 the patient developed 10 papular and vesicular areas on lower abdomen and right side of chest during 4 days and was diagnosed of VARICELLA by the Doctor.  It was reported that his brother had VARICELLA 1 1/2 week ago.  In December 2008 the patient was recovered.  Additional information is not expected.
Sex: U
Vaccine: VARCEL, VARZOS
Symptoms: Wrong drug administered
Clinical narrative: Information has been received from a certified medical assistant concerning a patient who on 12-DEC-2008 was inadvertently vaccinated with a dose of VARIVAX (Oka/Merck) instead of ZOSTAVAX (Oka/Merck).  It was reported that the patient had not experienced any known symptoms.  This is one of two reports from the same source.  Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Wrong drug administered
Clinical narrative: Information has been received from a certified medical assistant concerning a patient who on 15-DEC-2008 was inadvertently vaccinated with a dose of VARIVAX (Oka/Merck) instead of ZOSTAVAX (Oka/Merck).  It was reported that the patient had not experienced any known symptoms.  This is one of two reports from the same source.  Further information has been requested.
Age: 3.0
Sex: M
Vaccine: VARCEL
Symptoms: Pyrexia, Varicella, Varicella post vaccine
Clinical narrative: Information has been received from a registered nurse concerning a 4 year old male patient with asthma intermittent who on 13-APR-2008 was vaccinated with his first dose of VARIVAX (Oka/Merck) (Lot # 652550/1111R), subcutaneously in the right tight.  On 10-DEC-2008 the mother of the patient called the nurse to report that he was sent home from school with 4-5 spots on the trunk.  She also said that the school nursed stated VARICELLA with low-grade fever.  No other symptoms reported.  On 12-DEC-2008 the patient recovered.  No further information is available.
Sex: U
Vaccine: VARCEL
Symptoms: Antibody test negative, Varicella zoster serology negative
Clinical narrative: Information has been received from a physician concerning a patient who on an unknown date, received 2 doses of VARIVAX (Oka/Merck) (lot # not provided) and had a negative antibody.  The patient sought medical attention in the office.  Additional information has been requested.
Age: 25.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a physician concerning of his daughter a 25 year old who on an unspecified date was vaccinated with a dose of VARIVAX (Oka/Merck) (Lot # unspecified).  Subsequently, the patient developed chicken pox 10-14 days after she was vaccinated.  It is unknown if the patient sought medical attention.  At the time of reporting (02-DEC-2008) the outcome of the patient was unknown.  This is one of several reports from the same source.  Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a physician concerning a patient (a friend at school of his nephew) who on unspecified date was vaccinated with a dose of VARIVAX (Oka/Merck) (Lot # unspecified).  And after vaccination the patient developed a case of chicken pox.  It is unknown if the patient sought medical attention.  At the time of reporting (02-DEC-2008) the outcome of the patient was unknown.  This is one of several reports from the same source.  Additional information has been requested.
Age: 28.0
Sex: F
Vaccine: VARCEL
Symptoms: Antibody test negative, Varicella zoster serology negative
Clinical narrative: Information has been received from a consumer concerning a 28 year old daughter who 13 years ago (1993) was vaccinated with a dose of VARIVAX (Oka/Merck).  In 2008 a VARICELLA titer showed that her daughter did not have immunity to VARICELLA.  Patient was vaccinated with VARIVAX (Oka/Merck) 13 years before becoming pregnant.  As of 18-DEC-2008 the outcome of the patient was unknown.  Additional information has been requested.
Sex: F
Vaccine: VARCEL
Symptoms: Accidental exposure, Eye discharge, Ocular discomfort
Clinical narrative: Information has been received from a female licensed practical nurse, with asthma, who on 18-Dec-2008, splashed a VARIVAX (Oka/Merck) in her eye when she was drawing it up.  She reported that it was a fairly large amount and made the eye run.  She flushed water and was still experiencing mild discomfort.  She reported that a physician at the practice looked at the eye and gave her a prescription.  Additional information has been requested.
Age: 4.0
Sex: F
Vaccine: VARCEL
Symptoms: Pyrexia, Rash
Clinical narrative: Information has been received from a nurse concerning her daughter with environmental allergy.  In 1999-2001 when her daughter was 4-6 year old, her daughter was vaccinated with VARIVAX (Oka/Merck) (route and site not reported).  A few weeks or months after receiving VARIVAX (Oka/Merck), the patient developed a rash and fever.  Subsequently, the patient recovered from a rash and fever.  This is one of several reports received from the same source.  No further information is available.
Age: 2.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella, Varicella post vaccine
Clinical narrative: Information has been received from a nurse concerning a 24 month old female with a history of liver transplant who was vaccinated with a dose of VARIVAX (Oka/Merck).  Concomitant therapy included RAPAMUNE.  Subsequently the patient developed one small chicken pox lesion on  her forearm.  Subsequently, the patient recovered from one small chicken pox lesion on her forearm.
Age: 75.0
Sex: U
Vaccine: VARCEL
Symptoms: Wrong drug administered
Clinical narrative: Information has been received from a pharmacist concerning a 75 year old patient who on 29-DEC-2008 was vaccinated with VARIVAX (Oka/Merck) (lot # not provided) instead of with ZOSTAVAX (Oka/Merck) (not reported to be product confusion).  No adverse effect noted.  Patient sought unspecified medical attention.  Further information has been requested.